Sari Rasheed

Scientist @Helmholtz_HIPS 🇩🇪 | Target Identification & drug discovery | Focus: tuberculosis & AMR | Passionate about translational research & natural products

[Sari Rasheed @rasheed_sari]

Our latest paper is now published in @npjAMR
We show that Argyrin B effectively treats C. difficile infection in mice while preserving the gut microbiota, supporting its potential as a targeted therapeutic.
Read it here: https://t.co/ffGjlzHv8l

[Sari Rasheed @rasheed_sari]

https://t.co/x7J5vCNMrG

[Sari Rasheed @rasheed_sari]

#AMR is one of the biggest global health challenges of our time. Being part of a team at #HIPS that investigates nature’s chemical diversity and its potential for novel anti-infective agents is an important contribution to advancing our efforts against AMR.

[Sari Rasheed @rasheed_sari]

The Saarvienin story

https://t.co/kT0n55tp4g

[Sari Rasheed @rasheed_sari]

Attending the Helmholtz Imaging Conference 2025 in #Potsdam this week. Really enjoying both the main event and the zebrafish imaging pre-conference workshop! Inspiring science and discussions all around. 🐟📸🔬
@helmholtz_image

[Sari Rasheed @rasheed_sari]

If you know someone with an MSc in biochemistry, microbiology, biotechnology, or a related field who might be interested in pursuing a PhD in synthetic biology focused on developing living therapeutic materials, please reach out to me.

[Sari Rasheed @rasheed_sari]

@mmkaiss Thanks!🙏

[Sari Rasheed @rasheed_sari]

Excited to present at #ICA2025 on the development of mycoplanecins as potential antitubercular compounds! #Tuberculosis #DrugDiscovery

[Sari Rasheed @rasheed_sari]

@GoodSterny 🫡

[Sari Rasheed @rasheed_sari]

Happy to see our cover design featured on the front cover of this issue of Advanced Therapeutics!
Don’t forget to check out the paper on daptomycin-conjugation👇

[Sari Rasheed @rasheed_sari]

Check out our latest paper: "Antibiotic–Polycationic Peptide Conjugation as an Effective Strategy to Overcome Daptomycin Resistance." Happy to see part of my PhD work finally published in collaboration with Heidelberg University Hospital!

https://t.co/aui6CpwjP6

[Varun Tadimarri @Vrunvrun3]

Excited to share our latest work, published in a peer-reviewed journal. We studied how Gram +/- probiotic bacteria would adapt in mechanical confinements - key part in understanding the fundamentals of Engineered living materials. Read it here:

https://t.co/LvWg2HcEw1

[Sari Rasheed @rasheed_sari]

Check out our latest paper: "Antibiotic–Polycationic Peptide Conjugation as an Effective Strategy to Overcome Daptomycin Resistance." Happy to see part of my PhD work finally published in collaboration with Heidelberg University Hospital!

https://t.co/aui6CpwjP6

[Sari Rasheed @rasheed_sari]

@Tare_kh We hope so! It exhibits potent activity against multidrug-resistant pathogens, including strains that are resistant to last-resort antibiotics.
While it’s still early days, further studies are needed.

[Sari Rasheed @rasheed_sari]

Check out our latest publication on a newly discovered family of glycopeptides; Saarvienin, isolated from Amycolatopsis sp. found in a mine in China.

Saarvienin A exhibits potent activity against Gram-positive bacteria. @angew_chem

https://t.co/PYXy7ykxn3

[Sari Rasheed @rasheed_sari]

Check out our latest paper: "Antibiotic–Polycationic Peptide Conjugation as an Effective Strategy to Overcome Daptomycin Resistance." Happy to see part of my PhD work finally published in collaboration with Heidelberg University Hospital!

https://t.co/aui6CpwjP6

[Sari Rasheed @rasheed_sari]

Registration is NOW OPEN! 

Celebrating the 15th anniversary of the Helmholtz Institute for Pharmaceutical Research-Saarland (HIPS) by hosting the first International Conference on Anti-Infectives 2025.

Register now and learn more: 
https://t.co/FF8uK2hY4l

[Amr El-Demerdash @Eldemerdash83]

I am seeking for a potential PhD candidate for a research project on discovering new/novel therapeutics from marine derived streptomycese. Please feel free to get into touch.

https://t.co/lqsPHjxWz3

[César de la Fuente @delafuentelab]

Recently attended the @ESCMID symposium on #AI applications in the fight against antimicrobial resistance. Confident that #AI will fast-track new antibiotic discoveries. Thanks for the great discussions and invitation! Obrigado!

[Nat. Prod. Reports @NatProdReports]

🎉@NatProdReports is delighted to announce a special one day symposium held at @Helmholtz_HIPS!

Join us in celebrating our 40th anniversary with talks covering the breadth of natural product research!

📅Register for free by October 18th▶https://t.co/aYJqgabl3i

[Valeria Gigante @valeria_gigante]

✔ Antibacterial pipeline facts:

Did you know that of the 128 programmes in clinical development for priority pathogens, only 16 have received marketing authorization?

To know more read the 2023 WHO Antibacterial Pipeline analysis: https://t.co/8hQOQ2bPWV